Bessemer Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Bessemer Group’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-140	Closed	–	–	2607
2024 Q3	$0	Buy	+140	New	+$362	﹤0.01%	2664

Other funds holding NAUT

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bessemer Group's NAUT Position: Q4 2024 in Review

Bessemer Group sold out of Nautilus Biotechnolgy (NAUT) in Q4 2024, closing a stake of 140 shares.

Bessemer Group first reported a position in NAUT in Q3 2024 and held it in 1 quarter. The position peaked at $0 in Q3 2024. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

Bessemer Group reported no remaining Nautilus Biotechnolgy position as of Q4 2024 after selling out during the quarter.
Bessemer Group sold 140 Nautilus Biotechnolgy shares in Q4 2024.
Bessemer Group first reported a position in Nautilus Biotechnolgy in Q3 2024 and held it in 1 quarter.
Bessemer Group's Nautilus Biotechnolgy position peaked at $0 in Q3 2024.
88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on Bessemer Group's 13F filing for Q4 2024, filed 13 Feb 2025.